News

Ditch tobacco and limit alcohol. Smoking is strongly associated with colon cancer, says Lenz, so quitting tobacco is vital to ...
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...
This event is more than just a gathering of incredible vehicles; it’s a meaningful day that brings together car enthusiasts, ...
The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new ...
In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...
In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to ...
There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...
Eli Lilly (LLY) has won Health Canada approval for Omvoh (mirikizumab) in patients with Crohn’s disease, the company said on ...
Shannin Pain, from Canada, visited three different doctors after suffering from symptoms but was told the vomiting and bowel ...
Poo transplants are being used to help people battling painful gut conditions that are on the rise in Australia, with the ...
Eli Lilly Canada Inc. (Lilly Canada) announced today that Health Canada has approved Omvoh® (mirikizumab) for CD, which will soon be available to patients in Canada. Omvoh® is an interleukin-23p19 ...